Many studies have shown that α7nAChR could be an important therapeutic target for treatment of AD, because α7nAChR is involved in Aβ-induced neurotoxic effects both in vitro and in vivo [18], [19]. The gene discussed is CHRNA7; the disease is Alzheimer disease.